CClinicalTrials.gg
RecruitingNCT07245654ANIGAPPUpdated Nov 24, 2025

Monitoring the Depth of Anesthesia and Nociception During the Induction of General Anesthesia in Pediatric Patients

An observational study in Anaesthesia and Anesthesia Depth Monitoring, sponsored by Brno University Hospital. Recruiting at 1 site in Czechia. Open to participants aged 1 Year to 19 Years. Per ClinicalTrials.gov, last updated 2025-11-24.

Sponsored by Brno University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
1 Year to 19 Years
Sex
All
01

Study summary

Perioperative assessment of adequate depth of anesthesia and analgesia is currently a recommended part of routine anesthesia practice for all surgical procedures. In most cases, it is performed by monitoring and evaluating physiological parameters, which is insufficient, especially for the depth of anesthesia. The depth of anesthesia, when measured with the Conox device, is indicated by the qCON index, the recommended value for anesthesia management is between 40-60. Shallow (above 60) anesthesia may be associated with an increased incidence of perioperative wakefulness episodes, and deeper (below 40) anesthesia may lead to a more frequent occurrence of adverse effects of anesthesia, including emergent delirium in the postoperative period. In addition to assessing the depth of anesthesia, the Conox device also allows for instrumental assessment of analgesia. Inadequate analgesia increases postoperative discomfort and may contribute to an increased incidence of complications in anesthesia and during the postoperative period. Instrumental monitoring of the depth of anesthesia and analgesia increases the safety of anesthesia care. During perioperative care, periods with significant painful stimulation include not only the surgical procedure itself but also airway management during induction of general anesthesia, especially intubation. The hypothesis is - due to the significant painful stimulation during airway management during induction of anesthesia, adequate depth of anesthesia and analgesia may be insufficient and is associated with the patient's clinical response, which may be associated with the occurrence of postoperative delirium.

Read the detailed description

After approval by the Ethics Committee of the Brno University Hospital and registration at clinicaltrials.gov, the study will include patients meeting inclusive criteria. Pediatric patients aged 1 year to 19 years who undergo elective surgery under general anesthesia will be included in the study if the expected duration of the operation is more than 30 minutes.

Due to the observational nature of the study (no intervention, the monitoring used is a standard recommended part of anesthesia care), informed consent will not be required. Before induction of anesthesia, the electrodes of the CONOX device will be applied to the patient's forehead according to the manufacturer's recommendations and monitoring of the depth of anesthesia and analgesia will be initiated. Induction of anesthesia will be carried out according to the indications of the anesthesiologist (intravenously or by inhalation). During airway management, the depth of anesthesia and the level of analgesia and the patient's clinical response will be monitored. At the same time, the opioid analgesic used, the method of airway management and the occurrence of a burst suppression ratio will be monitored. Postoperatively, the occurrence of postoperative delirium in the recovery room will be monitored.

02

Conditions studied

  • Anaesthesia
  • Anesthesia Depth Monitoring

Keywords

  • depth of anesthesia
  • pediatric
  • nociception
  • awareness
  • depth of analgesia
  • airway management
03

Who can participate

Ages eligible
1 Year to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

- Pediatric patients (age 1-19 years) indicated for surgery under general anesthesia with airway management (laryngeal mask, orotracheal intubation, nasotracheal intubation) with expected duration of surgery more than 30 minutes

Inclusion criteria

  • Pediatric patients (age 1-19 years) indicated for surgery under general anesthesia with airway management (laryngeal mask, orotracheal intubation, nasotracheal intubation)
  • CONOX monitoring available

Exclusion criteria

Exclusion Criteria:

  • Age out of range
  • Use of ketamine during anesthesia care (premedication, analgesic, anesthetic)
  • Expected duration of surgery less than 30 minutes
  • CONOX monitoring unavailable
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Depth of anesthesia

    Assessment of the depth of anesthesia, level of analgesia during airway management during induction of anesthesia, clinical response of the patient.

    Time frame: Perioperative/Periprocedural

Secondary outcomes

  1. contributing factors

    Evaluation of the opioid analgesic used, method of airway management, the occurrence of BSR value above 0, the occurrence of postoperative delirium during recovery from anesthesia.

    Time frame: Perioperative/Periprocedural

06

Study locations

1 of 1 sites recruiting
  • University Hospital Brno
    Brno, 62500, Czechia
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07245654
Lead sponsor
Brno University Hospital
Responsible party
Petr Štourač, MD (prof. MUDr. Petr Štourač, Ph.D., LL.M, MBA, FESAIC, Brno University Hospital) — Principal investigator
First posted
Nov 24, 2025
Start date
Nov 10, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 24, 2025

Study contacts

Tereza Bonischova, MD
Contact
musilovate@gmail.com
00420724253223
Hana Harazim, MD, PhD
Contact
harazim.hana@fnbrno.cz
00420777146704
Petr Štourač, prof.MD.Ph.D
principal investigator · Brno University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion